Evaluating intermediate endpoints (IE) for overall survival (OS) in metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (ICI): An IMDC study.

Autor:	Saliby, Renee Maria, Xie, Wanling, Wells, J Connor, Saad, Eddy, Eid, Marc, Labaki, Chris, Semaan, Karl, Ferrier, Evan, Lemelin, Audreylie, Suárez, Cristina, Ruiz-Morales, Jose Manuel, Powles, Thomas, Wood, Lori, Ebrahimi, Hedyeh, de Velasco, Guillermo, Takemura, Kosuke null, Agarwal, Neeraj, Braun, David A., Heng, Daniel Yick Chin, Choueiri, Toni K.
Zdroj:	Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p400-400, 140p
Databáze:	Supplemental Index
Externí odkaz:	Zobrazit plný text záznamu